Cargando…
ADD3 Deletion in Glioblastoma Predicts Disease Status and Survival
Loss of heterozygosity (LOH) on chromosome 10 frequently occurs in gliomas. Whereas genetic loci with allelic deletion often implicate tumor suppressor genes, a putative tumor suppressor Adducin3 (ADD3) mapped to chromosome 10q25.2 was found to be preferentially downregulated in high-grade gliomas c...
Autores principales: | Kiang, Karrie Mei-Yee, Sun, Stella, Leung, Gilberto Ka-Kit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712675/ https://www.ncbi.nlm.nih.gov/pubmed/34970477 http://dx.doi.org/10.3389/fonc.2021.717793 |
Ejemplares similares
-
A Review on Adducin from Functional to Pathological Mechanisms: Future Direction in Cancer
por: Kiang, Karrie Mei-Yee, et al.
Publicado: (2018) -
Caffeine Sensitizes U87-MG Human Glioblastoma Cells to Temozolomide through Mitotic Catastrophe by Impeding G2 Arrest
por: Li, Ning, et al.
Publicado: (2018) -
Long Non-Coding RNAs: The Key Players in Glioma Pathogenesis
por: Kiang, Karrie Mei-Yee, et al.
Publicado: (2015) -
Secondary gliosarcoma: the clinicopathological features and the development of a patient-derived xenograft model of gliosarcoma
por: Kiang, Karrie Mei-Yee, et al.
Publicado: (2021) -
Lovastatin Enhances Cytotoxicity of Temozolomide via Impairing Autophagic Flux in Glioblastoma Cells
por: Zhu, Zhiyuan, et al.
Publicado: (2019)